1
|
Rambaud B, Joseph M, Tsai FC, De Jamblinne C, Strakhova R, Del Guidice E, Sabelli R, Smith MJ, Bassereau P, Hipfner DR, Carréno S. Slik sculpts the plasma membrane into cytonemes to control cell-cell communication. EMBO J 2025; 44:2186-2210. [PMID: 40050674 PMCID: PMC12000455 DOI: 10.1038/s44318-025-00401-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2024] [Revised: 02/08/2025] [Accepted: 02/19/2025] [Indexed: 04/17/2025] Open
Abstract
Cytonemes are signaling filopodia that facilitate long-range cell-cell communication by forming synapses between cells. Initially discovered in Drosophila for transporting morphogens during embryogenesis, they have since been identified in mammalian cells and implicated in carcinogenesis. Despite their importance, mechanisms controlling cytoneme biogenesis remain elusive. Here, we demonstrate that the Ser/Thr kinase Slik drives remote cell proliferation by promoting cytoneme formation. This function depends on the coiled-coil domain of Slik (SlikCCD), which directly sculpts membranes into tubules. Importantly, Slik plays opposing roles in cytoneme biogenesis: its membrane-sculpting activity promotes cytoneme formation, but this is counteracted by its kinase activity, which enhances actin association with the plasma membrane via Moesin phosphorylation. In vivo, SlikCCD enhances cytoneme formation in one epithelial layer of the wing disc to promote cell proliferation in an adjacent layer. Finally, this function relies on the STRIPAK complex, which controls cytoneme formation and governs proliferation at a distance by regulating Slik association with the plasma membrane. Our study unveils an unexpected structural role of a kinase in sculpting membranes, crucial for cytoneme-mediated control of cell proliferation.
Collapse
Affiliation(s)
- Basile Rambaud
- Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
- Programmes de biologie moléculaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
| | - Mathieu Joseph
- Programmes de biologie moléculaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
- Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, H2W 1R7, Canada
| | - Feng-Ching Tsai
- Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Physics of Cells and Cancer, 75005, Paris, France
| | - Camille De Jamblinne
- Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
- Programmes de biologie moléculaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
| | - Regina Strakhova
- Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
- Programmes de biologie moléculaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
| | - Emmanuelle Del Guidice
- Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
- Programmes de biologie moléculaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
| | - Renata Sabelli
- Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
- Programmes de biologie moléculaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
| | - Matthew J Smith
- Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
- Programmes de biologie moléculaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
- Département de Pathologie et Biologie cellulaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
| | - Patricia Bassereau
- Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Physics of Cells and Cancer, 75005, Paris, France
| | - David R Hipfner
- Programmes de biologie moléculaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada.
- Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, H2W 1R7, Canada.
- Département de Médecine, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada.
| | - Sébastien Carréno
- Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, Quebec, H3C 3J7, Canada.
- Programmes de biologie moléculaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada.
- Département de Pathologie et Biologie cellulaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada.
| |
Collapse
|
2
|
Marshall-Burghardt S, Migueles-Ramírez RA, Lin Q, El Baba N, Saada R, Umar M, Mavalwala K, Hayer A. Excitable Rho dynamics control cell shape and motility by sequentially activating ERM proteins and actomyosin contractility. SCIENCE ADVANCES 2024; 10:eadn6858. [PMID: 39241071 PMCID: PMC11378911 DOI: 10.1126/sciadv.adn6858] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Accepted: 07/31/2024] [Indexed: 09/08/2024]
Abstract
Migration of endothelial and many other cells requires spatiotemporal regulation of protrusive and contractile cytoskeletal rearrangements that drive local cell shape changes. Unexpectedly, the small GTPase Rho, a crucial regulator of cell movement, has been reported to be active in both local cell protrusions and retractions, raising the question of how Rho activity can coordinate cell migration. Here, we show that Rho activity is absent in local protrusions and active during retractions. During retractions, Rho rapidly activated ezrin-radixin-moesin proteins (ERMs) to increase actin-membrane attachment, and, with a delay, nonmuscle myosin 2 (NM2). Rho activity was excitable, with NM2 acting as a slow negative feedback regulator. Strikingly, inhibition of SLK/LOK kinases, through which Rho activates ERMs, caused elongated cell morphologies, impaired Rho-induced cell contractions, and reverted Rho-induced blebbing. Together, our study demonstrates that Rho activity drives retractions by sequentially enhancing ERM-mediated actin-membrane attachment for force transmission and NM2-dependent contractility.
Collapse
Affiliation(s)
- Seph Marshall-Burghardt
- Department of Biology, Stewart Biology Building, McGill University, Montréal, Québec H3A 1B1, Canada
- Graduate Program in Biology, McGill University, Montréal, Québec, Canada
| | - Rodrigo A Migueles-Ramírez
- Department of Biology, Stewart Biology Building, McGill University, Montréal, Québec H3A 1B1, Canada
- PhD Program in Quantitative Life Sciences, McGill University, Montréal, Québec, Canada
| | - Qiyao Lin
- Department of Biology, Stewart Biology Building, McGill University, Montréal, Québec H3A 1B1, Canada
- Graduate Program in Biology, McGill University, Montréal, Québec, Canada
| | - Nada El Baba
- Department of Biology, Stewart Biology Building, McGill University, Montréal, Québec H3A 1B1, Canada
- Graduate Program in Biology, McGill University, Montréal, Québec, Canada
| | - Rayan Saada
- Department of Biology, Stewart Biology Building, McGill University, Montréal, Québec H3A 1B1, Canada
| | - Mustakim Umar
- Department of Biology, Stewart Biology Building, McGill University, Montréal, Québec H3A 1B1, Canada
| | - Kian Mavalwala
- Department of Biology, Stewart Biology Building, McGill University, Montréal, Québec H3A 1B1, Canada
| | - Arnold Hayer
- Department of Biology, Stewart Biology Building, McGill University, Montréal, Québec H3A 1B1, Canada
| |
Collapse
|
3
|
Tsai FC, Guérin G, Pernier J, Bassereau P. Actin-membrane linkers: Insights from synthetic reconstituted systems. Eur J Cell Biol 2024; 103:151402. [PMID: 38461706 DOI: 10.1016/j.ejcb.2024.151402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2023] [Revised: 02/10/2024] [Accepted: 02/28/2024] [Indexed: 03/12/2024] Open
Abstract
At the cell surface, the actin cytoskeleton and the plasma membrane interact reciprocally in a variety of processes related to the remodeling of the cell surface. The actin cytoskeleton has been known to modulate membrane organization and reshape the membrane. To this end, actin-membrane linking molecules play a major role in regulating actin assembly and spatially direct the interaction between the actin cytoskeleton and the membrane. While studies in cells have provided a wealth of knowledge on the molecular composition and interactions of the actin-membrane interface, the complex molecular interactions make it challenging to elucidate the precise actions of the actin-membrane linkers at the interface. Synthetic reconstituted systems, consisting of model membranes and purified proteins, have been a powerful approach to elucidate how actin-membrane linkers direct actin assembly to drive membrane shape changes. In this review, we will focus only on several actin-membrane linkers that have been studied by using reconstitution systems. We will discuss the design principles of these reconstitution systems and how they have contributed to the understanding of the cellular functions of actin-membrane linkers. Finally, we will provide a perspective on future research directions in understanding the intricate actin-membrane interaction.
Collapse
Affiliation(s)
- Feng-Ching Tsai
- Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Physics of Cells and Cancer, Paris 75005, France.
| | - Gwendal Guérin
- Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Physics of Cells and Cancer, Paris 75005, France
| | - Julien Pernier
- Tumor Cell Dynamics Unit, Inserm U1279, Gustave Roussy Institute, Université Paris-Saclay, Villejuif 94800, France
| | - Patricia Bassereau
- Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Physics of Cells and Cancer, Paris 75005, France.
| |
Collapse
|
4
|
Leguay K, Decelle B, Elkholi IE, Bouvier M, Côté JF, Carréno S. Interphase microtubule disassembly is a signaling cue that drives cell rounding at mitotic entry. J Cell Biol 2022; 221:213183. [PMID: 35482006 DOI: 10.1083/jcb.202109065] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2021] [Revised: 02/03/2022] [Accepted: 04/05/2022] [Indexed: 11/22/2022] Open
Abstract
At mitotic entry, reorganization of the actomyosin cortex prompts cells to round-up. Proteins of the ezrin, radixin, and moesin family (ERM) play essential roles in this process by linking actomyosin forces to the plasma membrane. Yet, the cell-cycle signal that activates ERMs at mitotic entry is unknown. By screening a compound library using newly developed biosensors, we discovered that drugs that disassemble microtubules promote ERM activation. We further demonstrated that disassembly of interphase microtubules at mitotic entry directs ERM activation and metaphase cell rounding through GEF-H1, a Rho-GEF inhibited by microtubule binding, RhoA, and its kinase effector SLK. We finally demonstrated that GEF-H1 and Ect2, another Rho-GEF previously identified to control actomyosin forces, act together to drive activation of ERMs and cell rounding in metaphase. In summary, we report microtubule disassembly as a cell-cycle signal that controls a signaling network ensuring that actomyosin forces are efficiently integrated at the plasma membrane to promote cell rounding at mitotic entry.
Collapse
Affiliation(s)
- Kévin Leguay
- Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada.,Cellular Mechanisms of Morphogenesis during Mitosis and Cell Motility lab, Université de Montréal, Montréal, Quebec, Canada
| | - Barbara Decelle
- Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada.,Cellular Mechanisms of Morphogenesis during Mitosis and Cell Motility lab, Université de Montréal, Montréal, Quebec, Canada
| | - Islam E Elkholi
- Montréal Clinical Research Institute, Montréal, Quebec, Canada.,Cytoskeletal Organization and Cell Migration lab, Université de Montréal, Montréal, Quebec, Canada
| | - Michel Bouvier
- Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada.,institution>Molecular Pharmacology Lab, Université de Montréal, Montréal, Quebec, Canada.,Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Quebec, Canada
| | - Jean-François Côté
- Montréal Clinical Research Institute, Montréal, Quebec, Canada.,Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Quebec, Canada.,Department of Medicine, McGill University, Montréal, Quebec, Canada.,Department of Anatomy and Cell Biology, McGill University, Montréal, Quebec, Canada.,Cytoskeletal Organization and Cell Migration lab, Université de Montréal, Montréal, Quebec, Canada
| | - Sébastien Carréno
- Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada.,Cellular Mechanisms of Morphogenesis during Mitosis and Cell Motility lab, Université de Montréal, Montréal, Quebec, Canada.,Department of Pathology and Cell Biology, Université de Montréal, Montréal, Quebec, Canada
| |
Collapse
|
5
|
Avet C, Mancini A, Breton B, Le Gouill C, Hauser AS, Normand C, Kobayashi H, Gross F, Hogue M, Lukasheva V, St-Onge S, Carrier M, Héroux M, Morissette S, Fauman EB, Fortin JP, Schann S, Leroy X, Gloriam DE, Bouvier M. Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs. eLife 2022; 11:74101. [PMID: 35302493 PMCID: PMC9005190 DOI: 10.7554/elife.74101] [Citation(s) in RCA: 151] [Impact Index Per Article: 50.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Accepted: 03/17/2022] [Indexed: 11/25/2022] Open
Abstract
The recognition that individual GPCRs can activate multiple signaling pathways has raised the possibility of developing drugs selectively targeting therapeutically relevant ones. This requires tools to determine which G proteins and βarrestins are activated by a given receptor. Here, we present a set of BRET sensors monitoring the activation of the 12 G protein subtypes based on the translocation of their effectors to the plasma membrane (EMTA). Unlike most of the existing detection systems, EMTA does not require modification of receptors or G proteins (except for Gs). EMTA was found to be suitable for the detection of constitutive activity, inverse agonism, biased signaling and polypharmacology. Profiling of 100 therapeutically relevant human GPCRs resulted in 1500 pathway-specific concentration-response curves and revealed a great diversity of coupling profiles ranging from exquisite selectivity to broad promiscuity. Overall, this work describes unique resources for studying the complexities underlying GPCR signaling and pharmacology.
Collapse
Affiliation(s)
- Charlotte Avet
- Department of Biochemistry and Molecular Medicine, University of Montreal, Montréal, Canada
| | | | - Billy Breton
- Domain Therapeutics North America, Montréal, Canada
| | - Christian Le Gouill
- Department of Biochemistry and Molecular Medicine, University of Montreal, Montréal, Canada
| | | | | | - Hiroyuki Kobayashi
- Department of Biochemistry and Molecular Medicine, University of Montreal, Montréal, Canada
| | | | - Mireille Hogue
- Department of Biochemistry and Molecular Medicine, University of Montreal, Montréal, Canada
| | - Viktoriya Lukasheva
- Department of Biochemistry and Molecular Medicine, University of Montreal, Montréal, Canada
| | - Stéphane St-Onge
- Department of Biochemistry and Molecular Medicine, University of Montreal, Montréal, Canada
| | - Marilyn Carrier
- Department of Biochemistry and Molecular Medicine, University of Montreal, Montréal, Canada
| | - Madeleine Héroux
- Department of Biochemistry and Molecular Medicine, University of Montreal, Montréal, Canada
| | | | - Eric B Fauman
- Internal Medicine Research Unit, Pfizer Worldwide Research, Cambridge, United States
| | | | | | | | - David E Gloriam
- Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark
| | - Michel Bouvier
- Department of Biochemistry and Molecular Medicine, University of Montreal, Montréal, Canada
| |
Collapse
|